PHARMACY

Report: Teva, Mylan may buy Pfizer’s overseas generic business

BY Gina Acosta

Teva Pharmaceutical and Mylan have shown preliminary interest in a Brazilian generic drug-making joint-venture in which Pfizer has a 40% stake, according to Fortune. (Fortune)

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Benzer Pharmacy opens 3 new stores as franchise model builds momentum

BY Gina Acosta

TAMPA, Fla. — Independent chain Benzer Pharmacy has opened three new stores through its franchise model.

Franchisee Hetal Patel is opening a new pharmacy in Clermont, Fla., while franchisee Harry Patel, Siddharth Patel and Chetna Patel are opening another pharmacy in Immokalee, Fla. The third store is being opened in Poteau, Okla., by Jinal Desai.

Benzer Pharmacy, a chain of independent retail and specialty pharmacies, introduced its franchise model early this year with an aim of providing independent pharmacies with a platform to leverage their collective strength under one brand.

The company CEO Manish Patel, and president Alpesh Patel, said they are both excited about this new partnership. “Through the franchise model, Benzer Pharmacy will be in a strong position to negotiate prices with drug manufacturers,” Manish Patel said. 

Benzer Pharmacy says its franchisees receive: the credibility and recognition of a large national brand, reduced cost of goods and expenses, full access to expert HR, marketing, accounting, compliance and operational support, cutting edge business coaching to optimize all the key areas of operations, and access to the full spectrum of specialty medications.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Pa. gov signs biologics interchangeability bill

BY David Salazar
HARRISBURG, Pa. — Pennsylvania Gov. Tom Wolf last week signed a bill that will increase patient access to interchangeable biologic medicines. Wolf’s signing of Senate Bill 514 has earned him praise from both the Biotechnology Innovation Organization (BIO) and Pennsylvania Bio. 
 
“This bill includes provisions to ensure appropriate communication on all biologic medicines dispensed, in order to maintain a consistent and complete medical record,” Bio president and CEO Jim Greenwood said "By signing this bill into law, Governor Wolf has added Pennsylvania to the list of states that allow retail pharmacies to substitute interchangeable biologic medicines."
 
Although the Food and Drug Administration is in charge of vetting and approving biologic medicines and interchangeability designation, it’s up to the states to say whether one product may be substituted in place of a doctor’s prescription and whether a pharmacist must inform patients and doctors if they do so. BIO supports full communication in the substitution process to ensure patients and prescribers know what product the patient will receive. 
 
“We’re pleased to see Pennsylvania adopting policies that not only support a growing industry in our state, but more important, facilitate patient access to lower-cost, interchangeable therapies once approved as such by the FDA,” Pennsylvania Bio president and CEO Christopher Molineaux said. “This important bill will provide patients more opportunities to address their medical needs, particularly severely ill patients who rely on complex biological treatments.”
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?